Recent Security Class Actions

Tenax Therapeutics Inc. Common Stock (NASDAQ: TENX)

58 Days left to seek lead plaintiff status.

Company Name:Tenax Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: TENX
Class Period Start:11/13/2023
Class Period End (inclusive):08/07/2026
Filing Deadline:12/28/2026

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) TNX-103 was less effective than Defendants had led investors to believe; (ii) accordingly, TNX-103’s overall clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.  

Tenax Therapeutics Inc. Common Stock (NASDAQ: TENX) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address